[Multiple eruptive keratoacanthoma disclosing lymphoma].
Cabotin
P P
PP
Service de Dermatologie, Hôpital Saint-Louis, Paris.
Vignon-Pennamen
M D
MD
Miclea
J M
JM
D'Agay
M F
MF
Wallach
D
D
D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005050:Etretinate / Q000627:therapeutic use; D005148:Facial Dermatoses / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007636:Keratoacanthoma / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D008223:Lymphoma / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D009059:Mouth Diseases / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D009061:Mouth Mucosa / Q000473:pathology; D011239:Prednisolone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D005050:Etretinate; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone
Kérato-acanthomes multiples éruptifs révélateurs d'un lymphome.